Early research shows current FDA-approved drugs might be repurposed to calm COVID-19’s deadly cytokine storms…
dcorriganSeptember 6, 2021
Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia
A significant barrier to effective immunotherapy in AML is the shared immunophenotype between AML and…
dcorriganSeptember 3, 2021
Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, today announced…
dcorriganSeptember 3, 2021
The gleaming skyscrapers towering along Park Avenue always seemed opaque and out of reach to Dr.…
dcorriganSeptember 3, 2021
Our August Faculty Spotlight is Pulmonary, Critical Care and Sleep Medicine assistant professor Dr. Lisa Vande…
dcorriganSeptember 2, 2021
HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases, announced today that…
dcorriganSeptember 2, 2021
Bristol Myers Squibb just got some good news on its quest to transform aging arthritis…
dcorriganSeptember 1, 2021
Twins aren’t as rare as you might think. In fact, every human harbors many of…
dcorriganSeptember 1, 2021
My lab is working in two major directions – molecular evolution of human pathogens and…
dcorriganAugust 31, 2021
